Media

Today, the fourth industrial revolution is being fuelled by artificial intelligence (AI), which is disrupting and transforming almost every industry. Inevitably, the countries that invest most heavily in their successful domestic AI technology companies will rise in global presence. Canada is running in this race, but is not in first place.

CellCentric has discovered and patented a small molecule inhibitor that makes it more difficult for cancer cells to survive and thrive in the body. The company believes it could slow the advance of prostate, lung and bladder cancers. Globalive Chairman Anthony Lacavera sits down with the company’s Executive Chairman Will West. (Source: Bloomberg)